A Randomized Controlled Trial of an Integrated Care Intervention to Increase Eligibility for Chronic Hepatitis C Treatment
- Evon, Donna M
- Simpson, Kelly
- Kixmiller, Scott
- Galanko, Joseph
- Dougherty, Karen
- Golin, Carol
- Fried, Michael W
Publication date
January 2011
DOIAbstract
Mental health and substance abuse (MH/SA) comorbidities are the most oft-cited reasons for deferral from peginterferon (PegIFN) therapy for chronic hepatitis C virus (HCV). We sought to determine whether an integrated care intervention (INT) for patients deferred from PegIFN owing to MH/SA could improve subsequent treatment eligibility rates
Add to ORKG